Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 41 clinical trials
Cardiovascular Complications of Carfilzomib

Cardiovascular toxicity of carfilzomib, a last generation proteasome inhibitor, is highly incident according to retrospective data. Prospective cohort study of patients initiated on carfilzomib.

proteasome inhibitor
cardiovascular complications
carfilzomib
  • 0 views
  • 05 Aug, 2020